SMi’s 4th annual COPD: Novel therapeutics and Management Strategies conference
COPD: Novel Therapeutics & Management Strategies conference held on the 22nd & 23rd October in London will address therapeutic and management strategies for COPD with an international mix of key opinion leaders in this ever expanding field.
SMi is pleased to confirm Emma Baker, Professor of Clinical Pharmacology, St. George’s University of London to speak at the upcoming event
Professor Baker will be presenting on the effective management of COPD, what are the burdens to society, the patient and to the economy, computer guided diagnosis and treatment algorithms and lessons from Asthma that we can use in COPD.
This prestigious conference will be an industry-led event which will also encompass presentations from academic keynotes who aim to provide an unmatched forum for discussion and debate into pulmonary rehabilitation, novel COPD management strategies and innovative therapeutic developments. Attending will enable you to
Evaluate the benefits of anti-inflammatory drugs, alongside potential biological targets for therapeutic interventions in COPD
Compare and contrast diverse responses in COPD immunology
Hear from industry professionals on computer guided diagnosis and treatment algorithms
Assess co-morbidities in COPD and their relevance in pharmaceutical studies
Identify effective pharmacological interventions for the reduction of exacerbation frequency
Discuss the most relevant outcome parameters in COPD clinical trials
For more information visit http://www.smi-